Advertisement
On the conference call, Bruce Barrett, Somanetics' president and chiefexecutive officer, and Bill Iacona, chief financial officer, will reviewSomanetics' financial results and provide a business outlook for fiscal 2009.
Advertisement
To listen to the webcast, visit the Investor Center page of Somanetics'website at www.somanetics.com 15 minutes prior to the event's broadcast andclick on the "2008 Year-End Conference Call" link. Interested parties unableto listen to the live call may access the archived version of the call on theInvestor Center page of Somanetics' website for one year after the call.Windows Media Player is required for access to the webcast and is availablefor downloading free of charge on the webcast page.
About Somanetics
Somanetics Corporation (Nasdaq: SMTS) develops, manufactures and marketsthe INVOS(R) Cerebral/Somatic Oximeter, a non-invasive patient monitoringsystem that continuously measures changes in the blood oxygen levels in thebrain and elsewhere in the body in patients with or at risk for restrictedblood flow. Surgeons, anesthesiologists and other medical professionals canuse the information provided by the INVOS System, in conjunction with otheravailable information, to identify oxygen imbalances in tissues beneath thesensor and take necessary corrective action, potentially improving patientoutcomes and reducing the costs of care. The INVOS System has a nearly11-year market track record supported by more than 600 clinical references,and is used at nearly 700 U.S. hospitals. Somanetics supports its customersthrough a direct U.S. sales force and clinical education team. Covidienmarkets INVOS System products in Europe, Canada, the Middle East and SouthAfrica and Edwards Lifesciences represents INVOS System products in Japan.For more information visit www.somanetics.com.
SOURCE Somanetics Corporation